Influence of scaffold thickness and scaffold composition on bioartificial graft survival

被引:70
作者
Walles, T
Herden, T
Haverich, A
Mertsching, H
机构
[1] LEBAO, Leibniz Inst Bioartificial Organs, D-30625 Hannover, Germany
[2] Leibniz Univ Hannover, Sch Med, Div Thorac & Cardiovasc Surg, D-30167 Hannover, Germany
关键词
tissue engineering; scaffold; extracellular matrix; revascularization; elastin;
D O I
10.1016/S0142-9612(02)00490-8
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Biological scaffolds exhibit advantageous properties for tissue engineering of small diameter vessels. The influence of their extracellular matrix (ECM) components during in vivo repopulation is unknown. We implanted different xenogenic vascular matrices in a rat model to determine the influence of scaffold-thickness and ECM composition on in vivo repopulation. Decellularized ovine jugular vein (JV, n=42), carotid artery (CA, n=42) and aorta (AO, n=42) were implanted subcutaneously in the neck of adult male rats. Animals were sacrificed 2, 4 and 8 weeks after implantation. Cell and matrix morphology of explanted scaffolds were characterized by hematoxylin-eosin and pentachrome staining. Monoclonal anti-rat-CD31 was used to identify revascularization. Quantification of cell density was done by DNA-isolation. Thickness of implanted xenogenic scaffolds varied according to the material used (AO: 3.0-3.8 mm; CA: 0.7-0.88 mm; JV: 0.35-0.61 mm). Immunohistology revealed complete repopulation of AO, CA, and JV scaffolds with endothelial cells and myofibroblasts within 2 weeks. After 8 weeks of implantation, AO scaffolds were completely covered by an endothelial monolayer and showed signs of a central matrix degeneration. JV scaffolds were completely degenerated at this stage. In contrast, CA scaffolds showed preserved ECM with a normal myofibroblast population and endothelial cell coverage. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1233 / 1239
页数:7
相关论文
共 24 条
[11]   Diseases of the extracellular matrix [J].
Krieg, T ;
LeRoy, EC .
JOURNAL OF MOLECULAR MEDICINE-JMM, 1998, 76 (3-4) :224-225
[12]  
KU DN, 1995, BIOMEDICAL ENG HDB, P1985
[13]   Investigations on biological safety and immunologic aspects of chimeric bioartificial vessels in xenotransplantation [J].
Mertsching, H ;
Karim, N ;
Haverich, A ;
Bader, A .
TRANSPLANTATION PROCEEDINGS, 2000, 32 (05) :1165-1165
[14]   Viewpoint invariant characteristics of articulated objects [J].
Moons, T ;
vanGool, L ;
Pauwels, E ;
Oosterlinck, A .
JOURNAL OF MATHEMATICAL IMAGING AND VISION, 1996, 6 (01) :37-57
[15]   Vascular tissue engineering [J].
Nerem, RM ;
Seliktar, D .
ANNUAL REVIEW OF BIOMEDICAL ENGINEERING, 2001, 3 :225-243
[16]  
Robert L, 1995, CIBA F SYMP, V192, P286
[17]   Acellular vascular tissues: natural biomaterials for tissue repair and tissue engineering [J].
Schmidt, CE ;
Baier, JM .
BIOMATERIALS, 2000, 21 (22) :2215-2231
[18]   THE USE OF CD31 AND COLLAGEN-IV AS VASCULAR MARKERS - A STUDY OF 56 VASCULAR-LESIONS [J].
SCHMIDT, D ;
VONHOCHSTETTER, AR .
PATHOLOGY RESEARCH AND PRACTICE, 1995, 191 (05) :410-414
[19]  
Schoen FJ, 1999, J BIOMED MATER RES, V47, P439, DOI 10.1002/(SICI)1097-4636(19991215)47:4<439::AID-JBM1>3.3.CO
[20]  
2-F